Term
Estrogen Formulations, Uses, MOA, ADR's |
|
Definition
Oral Transdermal Vaginal IM
HRT/OC (often w/ pregesterone)
HRT: Replace what is lacking
OC: Convince body its pregnant (inhibit FSH/LH)
ADR's: Nausea/HA/↑ risk of clotting>35yo or smokers |
|
|
Term
|
Definition
Conjugated - Premarin
Estradiol - Estrace |
|
|
Term
|
Definition
Vivelle
Climara
Estraderm |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Medroxyprogesterone - Provera |
|
|
Term
Combination Estrogen/Medroxyprogesterone |
|
Definition
|
|
Term
Selective estrogen receptor modulators SERM's |
|
Definition
|
|
Term
Bisphosphonates, MOA, PK, ADR's |
|
Definition
Alendronate - Fosamax
Risendronate - Actonel
Ibandronate - Boniva
Inhibits osteoclastic activity: Osteoporisis/Paget's
Poor absorption, little metabolism, 10yr 1/2 life
ADR's: Nausea, Reflux, Osteonecrosis of jaw
|
|
|
Term
Insulins & Onset/Duration of action |
|
Definition
Rapid Acting
Short Acting
Intermediate Acting
Long Acting
Mixtures |
|
|
Term
|
Definition
Insulin Aspart - Novolog
Insulin Lispro - Humalog |
|
|
Term
Short Acting - Regular Insulin |
|
Definition
|
|
Term
Intermediate Acting - Isophane Insulin NPH (combined w/protamine & zinc) |
|
Definition
|
|
Term
|
Definition
Insulin glargine - Lantus |
|
|
Term
|
Definition
Humulin 70/30, 50/50 (intermediate/short)
Humalog 75/25 (intermediate/rapid) |
|
|
Term
|
Definition
|
|
Term
Sulfonylureas "Pancreas Spankers", MOA, ADR's |
|
Definition
Glipizide - Glucotrol/Glucotrol XL
Glyburide - Diabeta/Micronase
Glimepiride - Amaryl
MOA: binds to beta receptors and increases insulin release
ADR's: Hypoglycemia, Drug interactions
Amaryl specific: Tachycardia, hypokalemia, interacts w/non-selective beta-blockers |
|
|
Term
|
Definition
Metformin - Glucophage/Glucophage XR Glyburide/Metformin - Glucovance
MOA: ↓ gluconeogenesis, ↓ glucose absorption, ↑ insulin sensitivity, doesn't cause hypoglycemia
ADR's: Lactic acidosis, creatinine contraindication |
|
|
Term
Thiazidolinediones TZD's, MOA, ADR's |
|
Definition
Pioglitazone - Actos
Rosiglitazone - Avandia
MOA: PPRA gamma gene modulation, ↑ insulin sensitivity
ADR's: Swelling, liver issues (hepatotoxic), CV failure
|
|
|
Term
|
Definition
Repaglinide - Prandin
Nateglinide - Starlinx |
|
|
Term
Corticosteroid Formulations |
|
Definition
Topical
Injection
Enemas
Tabs |
|
|
Term
|
Definition
Prednisone
Methylprednisolone
>7.5mg dose >2wks requires tapering off |
|
|
Term
Thyroid Hormone - Synthetic T4; PK; ADR's |
|
Definition
Levothyroxine - Synthroid/Levoxyl/Levothroid
Well absorbed, >99% protein bound,
Hepatic metabolism, 7 day 1/2 life
Would indicate overdose (hyperthyroidism) |
|
|
Term
Diuretic Classes & MOA/Strength/ADR's |
|
Definition
Loop - Inhibit Na/K/Cl Cotransporter @ thick ascending loop; MOST POTENT; innefective in renal failure; Hypokalemia/Dehydration/Hyponatremia/Toxicity w/ACE
Thiazide - Inhibits Na/Cl Cotransporter at DCT; Mild; Hypokalemia/Hypercalcemia
K Sparing - Antagonize effects of aldosterone @ cortical CD / late DCT; Mild; Hyperkalemia/Gynomastia |
|
|
Term
|
Definition
Furosemide - Lasix
Bumetanide - Bumex
Torsemide - Demedex
Ethacrinic acid |
|
|
Term
|
Definition
Hydroclorothiazide HCTZ
Chlorthiladone
Metolazone - Zaroxolyn |
|
|
Term
|
Definition
Spironolactone
Triamterene |
|
|
Term
Impotence Agents & Duration of Action |
|
Definition
Sildenafil - Viagra; 4hrs
Vardenafil - Levitra; 4-6hrs
Tadalafil - Cialis; 36hrs |
|
|
Term
BPH Agents, specificity, ADR |
|
Definition
Prazosin - Minipress; worst for hypotension
Terazosin - Hytrin
Doxazosin - Cardura
Tamsulosin - Flowmax; Alpha 1a specific
ADR's: Hypotension, Fatigue, Dizziness, Asthenia; minimized by slow titration/QHS dosing |
|
|
Term
Urinary Anticholinergics, MOA, ADR |
|
Definition
Oxybtynin - Ditropan
Tolterodine - Detrol *highly specific*
Oxytrol patch
M3 Specific
Trosplum - Sanctura
Fesoteridine - Toviaz
Darifenacin - Enablex
Solifenacin - Vesicare
MOA: Bind to muscarinic receptor on SM of bladder
ADR's: Can't See/Pee/Spit/Shit, blurry vision, impaired cognition, dizziness, fatigue, dyspepsia |
|
|
Term
|
Definition
Allopurinol - Xanthine oxidase inhibitor = ↓ Uric Acid
Colchicine - ↓ lactic acid production by leukocytes/↓ inflammatory respones to crystals
|
|
|
Term
Difference b/w: Mono, Bi, Triphasic OC |
|
Definition
Monophasic - Fixed dose of estrogen/progesterone throughout cycle
Biphasic - Estrogen stays the same for first 21 days; Progesterone lower 1st half/higher 2nd half
Triphasic - Estrogen stays the same; Progesterone changes through cycle |
|
|
Term
Beta 2 Agonists, MOA, Length of action, ADR's |
|
Definition
Albuterol Aerosol - Short Acting "rescue"
Salmeterol - Long Acting "lipophilic"
MOA: B2 agonist = bronchodilation
*Most common Tx for asthma*
ADR's: Tachycardia, hypokalemia, interactions w/non-selective Beta-blockers
>1 canister/mo = overuse |
|
|
Term
Pulmonary Corticosteroids, MOA, ADR's |
|
Definition
Budesonide - Pulmicort
Fluticasone - Flovent
MOA: ↓ cytokines, ↓ inflammation/mucous production
ADR's: HA, throat itch, wheezing, thrush |
|
|
Term
Inhaled Anticholenergics, Length of action, MOA |
|
Definition
Ipatropium - Atrovent; Short acting QID
Tiotropium - Spiriva; Long acting QD
MOA: competitively inhibit Ach @ muscarinic receptors in airway = ↓ constriction/mucus
Combo Meds
Ipatropium/Albuterol - Combivent
Salmeterol/Fluticasone - Advair
|
|
|
Term
|
Definition
1st Gen: Benadryl - 4-6hrs
2nd Gen - 12-24hrs
Cetirizine - Zyrtec
Levocertizine - Xyzal
Fexofenadine - Allegra
Desloratidine - Clarinex
Misc: Olopatadine - Patanol (for watery eyes)
MOA: Antagonist to H1 receptors
1st Gen - central & peripheral
2nd Gen - peripheral (less ADR's)
|
|
|
Term
|
Definition
Triamcinolone Acetonide - Nasacort AQ
Budesonide - Rhinocort Aqua
Fluticasone - Flonase
Mometasone - Nasonex
MOA: Same as inhaled steroid |
|
|
Term
Leukotriene antagonist, MOA |
|
Definition
Montelukast - Singulair
MOA: Bind to LTD4/LTE4 receptors |
|
|
Term
H2 Antagonists, MOA, Potency |
|
Definition
Cimetidine - Tagamet
Ranitidine - Zantac
Famotidine - Pepcid
MOA: Block H2 receptors on parietal cells and prevent acid production
Potency: 60-70% of acid reduction |
|
|
Term
Proton Pump Inhibitors, MOA, Potency |
|
Definition
Omeprazole - Prilosec
Esemeprazole - Nexium
Rabeprazole - Aciphex
Pantoprazole - Protonix
Lansoprazole - Prevacid
MOA: Prodrugs that are activated by acid transport then bind covalently to H/K ATPase enzymes
Potency: 90-98% acid reduction
*↓ availability w/ food....Take on empty stomach* |
|
|
Term
|
Definition
Ondansetron - Zofran: 5-HT3 receptor antagonist
Prochlorperazine - Compazine
Promethazine - Phenergan: CTZ inhibitor of DA/Cholenergic transmission & ↓ gastric irritants
|
|
|
Term
|
Definition
Sucralfate - Carafate
MOA: Creates a physical barrier over ulcers & stimulate prostaglandin/bicarb secretion |
|
|
Term
|
Definition
Exenatide - Byetta
Liraglutide - Victoza |
|
|
Term
|
Definition
Ciprofloxacin - Cilox
Oflaxacin - Occuflox
Tobramycin/Dexamethasone - Tobradex |
|
|